Seer (SEER) Research & Development (2020 - 2026)
Seer (SEER) recorded quarterly Research & Development of $8.8 million in Q1 2026, down 9.61% quarter-over-quarter from $9.7 million in Q4 2025, and down 22.41% on a YoY basis from $11.4 million in Q1 2025.
Seer (SEER) Research & Development (2020 - 2026) Analysis & Trends
Seer's Research & Development history runs 7 years deep, the most recent figure standing at $8.8 million for Q1 2026.
- In Q1 2026, Research & Development fell 22.41% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $41.3 million (down 16.79% YoY), while the FY2025 annual figure was $43.9 million, down 13.27% from the prior year.
- Research & Development was $8.8 million for Q1 2026 at Seer, down from $9.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $14.5 million in Q1 2023 to a low of $8.8 million in Q1 2026.
- Historically, Research & Development has averaged $11.9 million across 5 years, with a median of $12.0 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Research & Development soared 72.35% in 2022, then decreased 22.8% in 2025.
- A 5-year view of Research & Development shows it stood at $12.6 million in 2022, then retreated by 11.6% to $11.2 million in 2023, then rose by 13.02% to $12.6 million in 2024, then slipped by 22.8% to $9.7 million in 2025, then slipped by 9.61% to $8.8 million in 2026.
- The last three Research & Development figures came in at $8.8 million (Q1 2026), $9.7 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 8.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.81 Mn |
| Dec 31, 2025 | 9.74 Mn |
| Sep 30, 2025 | 10.80 Mn |
| Jun 30, 2025 | 11.99 Mn |
| Mar 31, 2025 | 11.35 Mn |
| Dec 31, 2024 | 12.62 Mn |
| Sep 30, 2024 | 12.97 Mn |
| Jun 30, 2024 | 12.73 Mn |
| Mar 31, 2024 | 12.27 Mn |
| Dec 31, 2023 | 11.17 Mn |
| Sep 30, 2023 | 13.23 Mn |
| Jun 30, 2023 | 14.15 Mn |
| Mar 31, 2023 | 14.47 Mn |
| Dec 31, 2022 | 12.63 Mn |
| Sep 30, 2022 | 11.56 Mn |
| Jun 30, 2022 | 10.87 Mn |
| Mar 31, 2022 | 10.73 Mn |
| Dec 31, 2021 | 8.22 Mn |
| Sep 30, 2021 | 7.75 Mn |
| Jun 30, 2021 | 6.94 Mn |